Rontis was present for the 12th consecutive year at the EuroPCR congress, regarding products and techniques relevant to interventional cardiology and radiology. The congress was held in Paris from the 20 until the 23 of May, 2014.
Our company participated in the congress as an exhibitor, in order to promote its endovascular portfolio and pertinent services, to host its partners & distributors and to update the Scientific Community regarding our activities within the said field. Our marketing activities have increased, thus satisfying the need for increased visibility and promoting our vision to be one of the leading players in the international arena.
As usual, also during this year’s exhibition, significant interest from new candidate distributors has been shown for new exclusive partnerships and representation of our brand in their territory of cooperation.
Furthermore, given our recognized capabilities in research and development, as well as in manufacturing of innovative medical devices, several companies – as well as foreign government entities – have expressed the intention to realize their own projects with the support of our R&D and Production Teams in our facilities.
In conclusion, we can say that EuroPCR 2014 was a great opportunity for refreshing the global image of the Endovascular Department, as well as a springboard for the promotion of all Divisions and activities and services of our Corporation.
